Leaflet CASPOFUNGINA MYLAN 50mg powder for concentrate infusion solution


Indicated for: invasive candidiasis; fungal infections

Substance: caspofungin (antifungal)

ATC: J02AX04 (Antiinfectives for systemic use | Antimycotics for systemic use | Other antimycotics for systemic use)

Caspofungin is an antifungal medication used for the treatment of invasive fungal infections, such as invasive candidiasis and aspergillosis. It belongs to the echinocandin class and works by inhibiting the synthesis of the fungal cell wall, leading to fungal destruction.

Caspofungin is administered intravenously and is particularly indicated for patients who cannot tolerate other antifungals or who do not respond to standard treatments. The dosage is adjusted based on the patient's weight and the severity of the infection.

Treatment requires close monitoring to assess the patient's response and detect potential side effects. It is important for patients to inform their doctor about any other medications they are taking to avoid interactions.

Side effects may include fever, nausea, headache, injection site reactions, or, in rare cases, severe allergic reactions. Patients should inform their doctor of any unusual symptoms.

General data about CASPOFUNGINA MYLAN 50mg

  • Substance: caspofungin
  • Date of last drug list: 01-05-2026
  • Commercial code: W68225001
  • Concentration: 50mg
  • Pharmaceutical form: powder for concentrate infusion solution
  • Quantity: 1
  • Product type: generic
  • Price: 1060.01 RON
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: PHARMADOX HEALTHCARE, LTD - MALTA
  • Holder: MYLAN PHARMACEUTICALS LIMITED - IRLANDA
  • Number: 9741/2017/01
  • Shelf life: 2 years-after packing for marketing;after reconstituting the solution-it is used immediately

Concentrations available for caspofungin

  • 50mg
  • 70mg

Compensation lists for CASPOFUNGINA MYLAN 50mg Mylan

G10 (C1) - Leukemias, lymphomas and bone marrow aplasia, tumors

Price

Copayment

Patient

1060.01 RON

1060.01 RON

0.00 RON

GX (C1) - GENERIC (used in compensation list, C1, for another diagnosis)

Price

Copayment

Patient

1060.01 RON

1060.01 RON

0.00 RON

NHP 1.A (C2) - People with HIV/AIDS and post-exposure treatment

Price

Copayment

Patient

1060.01 RON

1060.01 RON

0.00 RON

NHP 9.1 (C2) - Spinal cord transplant

Price

Copayment

Patient

1060.01 RON

1060.01 RON

0.00 RON

NHP 9.3 (C2) - Liver Transplant

Price

Copayment

Patient

1060.01 RON

1060.01 RON

0.00 RON

NHP 9.4 (C2) - Kidney transplant, combined kidney and pancreas transplant

Price

Copayment

Patient

1060.01 RON

1060.01 RON

0.00 RON